Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: Aurora cannabis - The Untold Story

Curaleaf’s Higher Aurora Bid Raises the Stakes in Cannabis Consolidation

Curaleaf has raised its hostile bid for Aurora Cannabis to $5 per share as Schedule III tax relief fuels cannabis M&A, with Tilray's Oct. 8 earnings seen as a sector barometer.

MarketBeat · Oct 6

Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid

Curaleaf took a hostile, $4-per-share cash-and-stock tender offer for Aurora Cannabis directly to shareholders after private merger talks stalled, seeking global scale ahead of federal cannabis reforms.

MarketBeat · Sep 15

ACB Stock Alert: What to Know as Curaleaf Announces Takeover Bid for Aurora Cannabis

Aurora Cannabis shares rally as Curaleaf announces plans of an unsolicited takeover bid. Here’s what the development means for ACB shares.

Barchart · Aug 12

From analysis to the latest developments in health,
read the most diverse news in one place.

1 Stock I’d Buy Today, 1 I Wouldn’t Touch

Good investing isn’t just about what you buy but also what you avoid.

Barchart · Mar 20

Aurora Cannabis Is Spiking. Barchart Options Data Tells Us ACB Stock Could Be Headed Here Next.

Aurora Cannabis stock soars on President Donald Trump’s public endorsement of CBD as a viable alternative to prescription drugs. But investors are still recommended caution in buying ACB shares here.

Barchart · Sep 30, 2025

Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities

Aurora Cannabis (NASDAQ: ACB) stock finds support at $4.16 amid Fibonacci analysis and bullish divergence. Learn key levels for traders.

Benzinga · Nov 26, 2024

1 Cannabis Stock I Would Buy, and One I Would Avoid

The cannabis industry is rapidly growing, but will Canadian players be able to keep up?

Barchart · Oct 18, 2024

Read news from The Economist, FT, and more,
with one subscription

2 Cannabis Stocks I Would Flat-Out Avoid In 2024, and One I Would Buy

The cannabis industry is expanding rapidly, but only a few cannabis companies can be winners.

Barchart · Aug 29, 2024

Aurora Cannabis (ACB) vs. Merck (MRK): Which Pharma Stock Holds Greater Potential for Investors?

The pharmaceutical industry is poised for robust growth owing to technological advancements and growing healthcare needs. Given this backdrop, let’s analyze Aurora Cannabis (ACB) and Merck & Co. (MRK) to determine which of the two stocks holds greater potential for investors. Read on….

StockNews.com · Apr 5, 2024

Aurora Rolls Out An Extensive Line Of Medical & Recreational Cannabis Products

Aurora Cannabis (NASDAQ: ACB) (TSX:ACB) launched a new fall lineup of cannabis products. Drift:

Benzinga · Oct 17, 2022

Aurora Shares Plunge On Q4 Earnings Report But This Analyst Sees Better Days Ahead, Here's Why

Aurora Cannabis Inc. (NASDAQ: ACB) reported its financial and operational results for the fourth quarter and fiscal year ending June 30, 2022

Benzinga · Sep 21, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago quarter.

Benzinga · Sep 21, 2022

Akanda Partners With Berner's Cookies To Bring The Cannabis Brand And Its High THC Strains To Portugal

International medical cannabis platform company Akanda Corp. (NASDAQ: AKAN) signed an exclusive license agreement with international cannabis lifestyle brand Cookies.

Benzinga · Sep 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022

Upgrades

Benzinga · Jun 24, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Jun 24, 2022

Read Why Cantor Upgraded Aurora Cannabis Stock

Cantor Fitzgerald has upgraded Aurora Cannabis Inc (NASDAQ: ACB) to Overweight from Neutral

Benzinga · Jun 23, 2022

Aurora Cannabis Announces More Layoffs, Here's Why

Aurora Cannabis Inc. (NASDAQ: ACB) continues to trim its workforce as it seeks to achieve profitability.

Benzinga · Jun 14, 2022

Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 14, 2022

GAINERS: Aurora Cannabis (NASDAQ:ACB) shares closed up 5.65% at $1.31

StockNews.com · Jun 8, 2022

Is Aurora Cannabis a Buy Under $2?

With its stock currently trading at less than $2, Aurora Cannabis (ACB) has strengthened its portfolio and made considerable progress in the worldwide medicinal cannabis market. However, given that the company is struggling to generate revenue growth in the consumer cannabis segment, is it worth buying the stock now? Read…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Jun 6, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2022

Upgrades

Benzinga · Jun 3, 2022

Aurora Cannabis Repurchases $20M Of Convertible Notes

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB), has repurchased an aggregate of approximately CA$25.3 million ($20 million) principal amount of its convertible senior notes at a total cost, including accrued interest, of CA$24.3 million ($19.2 million) in cash.

Benzinga · Jun 1, 2022

Aurora Cannabis Closes $172.5M Bought Deal Financing, Here Are The Details

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) closed bought deal offering of units of the company for gross proceeds of approximately $172.5 million. The company sold approximately 70.4 million units at a price of $2.45 per unit, including approximately 9.2 million units sold pursuant to the

Benzinga · May 27, 2022

Aurora Cannabis Upsizes Bought Deal Financing

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB), has amended the terms of its previously announced bought deal financing.

Benzinga · May 27, 2022

Why Aurora Cannabis Stock Is Getting Hammered Today

Aurora Cannabis Inc. (NASDAQ: ACB) shares are trading lower after the company announced it has enetered into a bought deal financing agreement. Aurora announced today that it has amended the terms of its previously announced bought deal financing.

Benzinga · May 18, 2022

Aurora Gets EU-GMP Certification For Its Cannabis Production Facility In Germany

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has received EU-GMP certification for its state-of-the-art medical cannabis production facility in Germany.

Benzinga · May 12, 2022

Recap: Aurora Cannabis Q3 Earnings

Aurora Cannabis (NASDAQ:ACB) reported its Q3 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Aurora Cannabis missed estimated earnings by 83.33%, reporting an EPS of $-0.33 versus an estimate of $-0.18.

1 2

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.